title: Effects of caffeine and its metabolite paraxanthine on intracranial self-stimulation in male rats.
abstract: Caffeine is the most widely used psychostimulant in the world, though preclinical studies suggest weaker evidence for abuse-related effects than stimulants with high abuse liability, such as amphetamine or cocaine. Intracranial self-stimulation (ICSS) is 1 procedure used to assess the abuse liability of drugs, and previous studies have produced mixed results regarding whether caffeine produces an abuse-related facilitation of ICSS. This study assessed both caffeine and its main metabolite in humans, paraxanthine, using a frequency-rate ICSS procedure and compared their effects to those of amphetamine and cocaine. Male Sprague-Dawley rats were implanted with intracranial electrodes targeting the medial forebrain bundle and trained to respond under a fixed-ratio 1 schedule for brain stimulation that varied across a range of frequencies (56-158 Hz in 0.05 log increments). Data analysis focused on 3 dependent measures: reinforced responding (defined as responses that produced brain stimulation), nonreinforced responding (defined as responses that occurred during each 0.5 s brain stimulation and that did not produce additional stimulation), and total responding (reinforced plus nonreinforced responding). Both amphetamine and cocaine produced robust increases in total, reinforced, and nonreinforced responses. Caffeine also increased total, reinforced, and nonreinforced responses, but the caffeine dose-effect curve had an inverted-U shape, and peak ICSS facilitation was less than that produced by amphetamine or cocaine. Paraxanthine increased only total responses and nonreinforced responses. These results suggest that paraxanthine has low abuse liability and does not mediate abuse-related effects of caffeine.
authors.affiliation: Department of Pharmacology and Toxicology, Virginia Commonwealth University.
authors.forename: Matthew F
authors.initials: MF
authors.lastname: Lazenka
authors.affiliation: Institute for Drug and Alcohol Studies, Virginia Commonwealth University.
authors.forename: F Gerard
authors.initials: FG
authors.lastname: Moeller
authors.affiliation: Department of Pharmacology and Toxicology, Virginia Commonwealth University.
authors.forename: S Stevens
authors.initials: SS
authors.lastname: Negus
mesh_terms: D000818:Animals; D002110:Caffeine / Q000008:administration & dosage*; D003216:Conditioning, Operant / Q000187:drug effects / Q000502:physiology; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D012054:Reinforcement, Psychology; D012646:Self Administration; D012653:Self Stimulation / Q000187:drug effects* / Q000502:physiology; D013806:Theophylline / Q000008:administration & dosage* / Q000378:metabolism
chemical_list: D002110:Caffeine; D013806:Theophylline; C021183:1,7-dimethylxanthine
references.citation: Pharmacol Biochem Behav. 1976 Jan;4(1):73-83
references.pmid: 4819
references.citation: Br J Pharmacol. 2013 Feb;168(4):850-62
references.pmid: 22978626
references.citation: Handb Exp Pharmacol. 2011;(200):33-91
references.pmid: 20859793
references.citation: Psychiatry Clin Neurosci. 2007 Jun;61(3):263-8
references.pmid: 17472594
references.citation: Eur Neuropsychopharmacol. 1998 Dec;8(4):287-91
references.pmid: 9928918
references.citation: Psychopharmacologia. 1966;9(2):157-69
references.pmid: 5983914
references.citation: J Neurochem. 2007 Apr;101(2):355-63
references.pmid: 17254024
references.citation: Psychopharmacology (Berl). 2014 Jun;231(12):2461-70
references.pmid: 24408209
references.citation: Clin Ther. 2015 Feb 1;37(2):275-301
references.pmid: 25262198
references.citation: J Caffeine Res. 2013 Sep;3(3):114-130
references.pmid: 24761279
references.citation: Clin Pharmacol Ther. 1986 Jan;39(1):54-9
references.pmid: 3943270
references.citation: J Pharmacol Exp Ther. 1989 Jan;248(1):315-9
references.pmid: 2913277
references.citation: Neurosci Biobehav Rev. 1999 Mar;23(4):563-76
references.pmid: 10073894
references.citation: Ergeb Physiol. 1968;60:1-56
references.pmid: 4874179
references.citation: Psychopharmacology (Berl). 1988;95(1):19-24
references.pmid: 3133696
references.citation: Pharmacol Biochem Behav. 1988 Feb;29(2):419-27
references.pmid: 3283780
references.citation: Brain Res. 1991 May 31;550(1):172-8
references.pmid: 1888997
references.citation: Psychopharmacology (Berl). 2011 Jul;216(2):173-86
references.pmid: 21347642
references.citation: Eur Neuropsychopharmacol. 1999 Sep;9(5):377-83
references.pmid: 10523044
references.citation: Psychopharmacology (Berl). 1982;76(4):325-8
references.pmid: 6812105
references.citation: Drug Test Anal. 2011 Sep;3(9):576-81
references.pmid: 21595051
references.citation: Behav Pharmacol. 1999 Dec;10(8):739-46
references.pmid: 10780289
references.citation: Behav Pharmacol. 2013 Sep;24(5-6):448-58
references.pmid: 23851484
references.citation: Brain Res. 1990 Sep 24;528(1):32-8
references.pmid: 2245338
references.citation: J Exp Anal Behav. 1979 Nov;32(3):445-56
references.pmid: 512573
references.citation: Behav Pharmacol. 1999 Feb;10(1):15-26
references.pmid: 10780299
references.citation: Nat Protoc. 2007;2(11):2987-95
references.pmid: 18007634
references.citation: Neuropharmacology. 2013 Apr;67:476-84
references.pmid: 23261866
references.citation: Drug Alcohol Depend. 2009 Jan 1;99(1-3):1-10
references.pmid: 18809264
references.citation: Pharmacol Biochem Behav. 1987 Jun;27(2):299-306
references.pmid: 3628444
references.citation: Psychol Addict Behav. 2012 Dec;26(4):948-54
references.pmid: 22369218
references.citation: J Neurochem. 2004 Mar;88(5):1151-8
references.pmid: 15009670
references.citation: Biull Eksp Biol Med. 1976 Jan;81(1):43-5
references.pmid: 1247677
references.citation: Behav Pharmacol. 2011 Oct;22(7):663-73
references.pmid: 21921839
references.citation: Brain Res. 1988 Aug 30;459(1):163-7
references.pmid: 3167574
references.citation: Annu Rev Neurosci. 1996;19:319-40
references.pmid: 8833446
references.citation: Pharmacol Rev. 2014 Jul;66(3):869-917
references.pmid: 24973197
references.citation: Am J Psychiatry. 2013 Aug;170(8):834-51
references.pmid: 23903334
references.citation: Neurosci Lett. 1996 Jul 5;212(1):53-6
references.pmid: 8823761
references.citation: Pharmacol Biochem Behav. 1991 Mar;38(3):513-7
references.pmid: 2068188